PrOmnitrope® (somatropin for injection) is a recombinant human growth hormone used to treat growth problems in both pediatric and adult patients. PrOmnitrope® was the first subsequent entry biologic (biosimilar) launched on the Canadian market. Biosimilars are follow-on versions of original biological molecules and unlike most generic copies of chemical medicines undergo their own safety and efficacy clinical studies.
Click here to consult the product monograph of Omnitrope®.
® : Registered trademark owned or used under license by Sandoz Canada Inc.